| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +15% |
| 3Y CAGR | +159% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +22% |
| 3Y CAGR | +139% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,325.60 -50.50 (2.13%) | 18,042.14 | 26.61 | 5.35 | ||
PfizerPFIZER | ₹3,687.80 -72.00 (1.91%) | 17,202.98 | 23.4 | 4.09 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,364.50 +65.50 (1.04%) | 15,745.13 | 92.82 | 18.04 | ||
Natco PharmaNATCOPHARM | ₹782.40 -5.15 (0.65%) | 15,453.13 | 13.5 | 1.47 |